Research ArticleClinical Studies
A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
HIRONORI YOSHIDA, YOUNG HAK KIM, YUICHI SAKAMORI, HIROKI NAGAI, HIROAKI OZASA, TOSHIHIKO KANEDA, HIROSHIGE YOSHIOKA, HIROAKI NAKAGAWA, KEISUKE TOMII, ASUKA OKADA, KENICHI YOSHIMURA, MASATAKA HIRABAYASHI and TOYOHIRO HIRAI
Anticancer Research May 2020, 40 (5) 2981-2987; DOI: https://doi.org/10.21873/anticanres.14278
HIRONORI YOSHIDA
1Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
YOUNG HAK KIM
1Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
YUICHI SAKAMORI
2Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
HIROKI NAGAI
2Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
HIROAKI OZASA
1Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
TOSHIHIKO KANEDA
3Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan
4Department of Respiratory Medicine, Kobe City Medical Center West Hospital, Kobe, Japan
HIROSHIGE YOSHIOKA
3Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan
5Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan
HIROAKI NAKAGAWA
6Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Shiga, Japan
KEISUKE TOMII
7Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan
ASUKA OKADA
8Department of Respiratory Medicine, Saiseikai Suita Hospital, Suita, Japan
9Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan
KENICHI YOSHIMURA
10Center for Integrated Medical Research, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan
MASATAKA HIRABAYASHI
1Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
TOYOHIRO HIRAI
1Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
In this issue
A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
HIRONORI YOSHIDA, YOUNG HAK KIM, YUICHI SAKAMORI, HIROKI NAGAI, HIROAKI OZASA, TOSHIHIKO KANEDA, HIROSHIGE YOSHIOKA, HIROAKI NAKAGAWA, KEISUKE TOMII, ASUKA OKADA, KENICHI YOSHIMURA, MASATAKA HIRABAYASHI, TOYOHIRO HIRAI
Anticancer Research May 2020, 40 (5) 2981-2987; DOI: 10.21873/anticanres.14278
A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
HIRONORI YOSHIDA, YOUNG HAK KIM, YUICHI SAKAMORI, HIROKI NAGAI, HIROAKI OZASA, TOSHIHIKO KANEDA, HIROSHIGE YOSHIOKA, HIROAKI NAKAGAWA, KEISUKE TOMII, ASUKA OKADA, KENICHI YOSHIMURA, MASATAKA HIRABAYASHI, TOYOHIRO HIRAI
Anticancer Research May 2020, 40 (5) 2981-2987; DOI: 10.21873/anticanres.14278
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.